Expression and retinoid modulation of N-arginine dibasic convertase and an aminopeptidase-B in human neuroblastoma cell lines

Muriel Draoui, Lorenza Bellincampi, Véronique Hospital, Sandrine Cadel, Thierry Foulon, Annik Prat, Nicole Barré, Uwe Reichert, Gerry Melino, Paul Cohen

Research output: Contribution to journalArticlepeer-review

Abstract

Under retinoic acid exposure, the three SK-N-BE(2)-derived human neuroblastoma cell lines, BE(2)-NA, BE(2)-SA and BE(2)-M17 undergo mainly differentiation, apoptosis or continue to proliferate, respectively. We have used this model system to study the modulation of the transcriptional expression of putative processing enzymes, two novel metallopeptidases; i.e. N-arginine dibasic convertase (NRD convertase; EC 3.4.24.61) and an aminopeptidase-B after exposure of the cells either to retinoic acid or to synthetic retinoid analogs. The data indicate that the two respective enzymes are differently modulated in the various cell lines. Whereas aminopeptidase-B expression is enhanced in most cases, NRD convertase appears to undergo opposite regulation in proliferating versus differentiating neuroblastoma cells. It is concluded that both genes might contain retinoic acid regulatory elements (RARE) in their promoters.

Original languageEnglish
Pages (from-to)99-106
Number of pages8
JournalJournal of Neuro-Oncology
Volume31
Issue number1-2
DOIs
Publication statusPublished - 1997

Keywords

  • Aminopeptidase-β
  • Apoptosis
  • Neuroblastoma
  • NRII convertase
  • Retinoic acid

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Expression and retinoid modulation of N-arginine dibasic convertase and an aminopeptidase-B in human neuroblastoma cell lines'. Together they form a unique fingerprint.

Cite this